Filing Details
- Accession Number:
- 0000904454-16-001467
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-04 16:12:38
- Reporting Period:
- 2016-09-30
- Filing Date:
- 2016-10-04
- Accepted Time:
- 2016-10-04 16:12:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1105533 | Argos Therapeutics Inc | ARGS | Pharmaceutical Preparations (2834) | 562110007 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1598754 | Public Joint Stock Co Pharmstandard | Likhacevsky Drive 5 &Quot;B&Quot; Dolgoprudny 1Z 141700 | No | No | Yes | No | |
| 1598762 | S.a. International Pharmstandard | 10A, Rue Henry Schnadt Luxembourg N4 L-2530 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-09-30 | 30,232 | $4.71 | 13,199,567 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2016-10-03 | 11,308 | $4.70 | 13,210,875 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $4.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- Pharmstandard International S.A. is a wholly owned subsidiary of Public Joint Stock Company Pharmstandard. As the parent entity, Public Joint Stock Company Pharmstandard has voting power over the shares of the Issuer held by Pharmstandard International S.A.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $4.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Billionaire Hedge Funds
